MedEdTalks - Pulmonology

Case Studies on the Use of IO in NSCLC With Drs. Jeffrey Kern and Laurie Carr

Updates on the Use of Neoadjuvant and Adjuvant IO in Patients With NSCLC With Drs. Laurie Carr and Heather Wakelee

Updates in IO for Advanced NSCLC – Options for First-line Treatment and Management of Progressive Disease With Drs. Laurie Carr and Heather Wakelee

NSCLC: Updates in Testing and Interpreting Results – Focus on IO With Drs. Laurie Carr and David Ross Camidge

NSCLC: Optimizing Care Coordination – Through the Patient and Caregiver’s Eyes

Lung Cancer Advances and Challenges During a Pandemic – Where Do We Go From Here? With Drs. Jeffrey Kern and Charu Aggarwal

The Importance of Patient Education on Adherence to Therapies in IPF with Drs. Robert J. Kaner and Maria Padilla

In this podcast, expert clinicians will discuss best practice for improving patient-provider communication to improve adherence to IPF therapies.

Long-term Outcomes with IPF Therapies with Drs. Maria Padilla and Steven D. Nathan, MD

In this podcast, expert clinicians will discuss the most recent data regarding long-term outcomes with current therapies for IPF.

The Importance of Early and Accurate Diagnosis in IPF with Drs. Maria Padilla and Robert J. Kaner

In this podcast, expert clinicians will discuss evidence-based best practices for making early and accurate diagnoses in IPF.

Improving Adherence: Patient Engagement and Education With Drs. Elizabeth R. Volkmann and Kristin B. Highland

In this podcast, expert clinicians will discuss the strategies to improve patients adherence to therapy in SSc-ILD.

Management of SSc-ILD: Guidelines and Treatment Options With Drs. Elizabeth R. Volkmann and Kevin R. Flaherty

In this podcast, expert clinicians will discuss evidence-based recommendations for the treatment of SSc-ILD.

Diagnosis of SSc-ILD: Screening and Monitoring of Lung Function With Drs. Elizabeth R. Volkmann and Kristin B. Highland

In this podcast, expert clinicians will discuss best practices in the diagnosis of SSc-ILD.

Understanding SSc-ILD: Prevalence and Burden of Disease With Drs. Elizabeth R. Volkmann and Kevin R. Flaherty

In this podcast, expert clinicians will discuss the prevalence and burden of SSc-ILD.

Treating a Patient With Refractory Nontuberculous Mycobacterial Lung Disease, with Drs. Anne O’Donnell and David Griffith

In this podcast, expert clinicians will discuss treatment for a patient with refractory Mycobacterium avium complex lung disease despite many months of guidelines-based therapy.    For CME Credit, complete activity here: https://tinyurl.com/LungMET2

Managing Mycobacterium Avium Complex Lung Infection in a Patient With Underlying Lung Disease, with Drs. Anne O’Donnell and Angela DiMango

In this podcast, expert clinicians will discuss treatment for Mycobacterium avium complex lung infection in a patient with underlying granulomatosis with polyangiitis affecting the lungs.    For CME Credit, complete activity here: https://tinyurl.com/LungMET1

Dr. Nathan and Dr. Patel Discuss a Challenging Case in Treating PF-ILD

Interstitial lung disease (ILD) describes a group of over more than 200 rare pulmonary conditions characterized by fibrosis of the lung. ILD can have several causes, including environmental antigens, bacterial, viral, and fungal infections, gastroesophageal reflux, occupational hazards (eg, asbestos), or a connective tissue disease (CTD). Patients with systemic sclerosis (SSc), rheumatoid arthritis (RA), or poly-/dermatomyositis (PM/DM), have the greatest risk of developing CTD-associated IL...

Dr. Nathan and Dr. Patel Discuss a Challenging Case in Diagnosing PF-ILD

Interstitial lung disease (ILD) describes a group of over more than 200 rare pulmonary conditions characterized by fibrosis of the lung. ILD can have several causes, including environmental antigens, bacterial, viral, and fungal infections, gastroesophageal reflux, occupational hazards (eg, asbestos), or a connective tissue disease (CTD). Patients with systemic sclerosis (SSc), rheumatoid arthritis (RA), or poly-/dermatomyositis (PM/DM), have the greatest risk of developing CTD-associated IL...

Dr. Nathan and Dr. Lancaster Discuss a Challenging Case in Treating PF-ILD

Interstitial lung disease (ILD) describes a group of over more than 200 rare pulmonary conditions characterized by fibrosis of the lung. ILD can have several causes, including environmental antigens, bacterial, viral, and fungal infections, gastroesophageal reflux, occupational hazards (eg, asbestos), or a connective tissue disease (CTD). Patients with systemic sclerosis (SSc), rheumatoid arthritis (RA), or poly-/dermatomyositis (PM/DM), have the greatest risk of developing CTD-associated IL...

Dr. Nathan and Dr. Lancaster Discuss a Challenging Case in Diagnosing PF-ILD

Interstitial lung disease (ILD) describes a group of over more than 200 rare pulmonary conditions characterized by fibrosis of the lung. ILD can have several causes, including environmental antigens, bacterial, viral, and fungal infections, gastroesophageal reflux, occupational hazards (eg, asbestos), or a connective tissue disease (CTD). Patients with systemic sclerosis (SSc), rheumatoid arthritis (RA), or poly-/dermatomyositis (PM/DM), have the greatest risk of developing CTD-associated IL...

Optimizing the Care of Patients With Progressive-Fibrosing Interstitial Lung Disease: Applying the Latest Data

The intended audience for this series is pulmonologists, internists, rheumatologists and other health care professionals involved in the management of patients with progressive fibrosing interstitial lung disease (PF-ILD).